Live Breaking News & Updates on Prnewswire Neuroplast

Stay updated with breaking news from Prnewswire neuroplast. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells treatment for Traumatic Spinal Cord Injury

Neuro-Cells treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following traumaThe randomized, placebo-controlled, international multi-center ....

United States , Noord Holland , Kostenloser Wertpapierhandel , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Agencia Espanola De Medicamentos , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest ,

Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury

Neuro-Cells® treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation following trauma The randomized,. ....

United States , Noord Holland , Agencia Espa , Erik Wolters , Prnewswire Neuroplast , Antonio Oliviero , Medicamentosy Productos Sanitarios , Brightlands Agrifood Fund , National Videnskabsetisk Komit , Netherlands Enterprise Agency , Danish Medicines Agency , Dutch Ministry Of Economic Affairs , Traumatic Spinal Cord Injury , Traumatic Brain Injury , Frontotemporal Dementia , Hospital Nacional De Parapl , Principal Investigators Antonio Oliviero , Hospital Parapl , Principal Investigator , Spinal Cord Injury , Spinal Cord , Productos Sanitarios , Danish Medicines , Johannes De Munter , Lumana Invest , Brightlands Venture Partners ,

Dutch stem cell biotech Neuroplast appoints TiGenix founder Frank Luyten and Sanquin director Pieter De Geus to its supervisory board

- Appointments instrumental in the further development of advanced cell-based therapies for inflammation-driven neurological disorders GELEEN, Netherlands, Oct. 21, 2021 /PRNewswire/ ....

Noord Holland , Gil Beyen , Erik Wolters , Wim Brouwer , Marcel Kloosterman , Frank Luyten , Kostenloser Wertpapierhandel , Prnewswire Neuroplast , Sasja Verhoog , Dutch Sanquin Health Solutions , Sanquin Health Solutions , Sanquin Foundation , Pieter De Geus , Managing Director , Traumatic Spinal Cord , Belgian Tigenix , Professor Emeritus , Advanced Therapy Medicinal Products , Traumatic Spinal Cord Injury , Johannes De Munter , Lumana Invest , Brightlands Chemelot Campus , Spring Lifesciences Communication ,